Moreover, the dynamic changes of pro-inflammatory neutrophils and CRP indicated that the neutrophils count and the level of CRP in non-surviving patients remain at an overall higher level and gradually increase, and compared with COVID-19 patients without cancer, cancer patients with COVID-19 showed a higher neutrophil count and higher levels of CRP, meanwhile showed more critical illness and higher mortality rate. This evidence concerns the gene CRP and COVID-19.